Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials-Reference-Cited by-同舟云学术

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

Published:2014-09 Issue:9 Volume:2 Page:738-749
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Barker Alan F,O'Donnell Anne E,Flume Patrick,Thompson Philip J,Ruzi Jonathan D,de Gracia Javier,Boersma Wim G,De Soyza Anthony,Shao Lixin,Zhang Jenny,Haas Laura,Lewis Sandra A,Leitzinger Sheila,Montgomery A Bruce,McKevitt Matthew T,Gossage David,Quittner Alexandra L,O'Riordan Thomas G

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference28 articles.

1. Bronchiectasis;Barker;N Engl J Med,2002

2. Bronchiectasis;O'Donnell;Chest,2008

3. Microbiologic follow-up study in adult bronchiectasis;King;Respir Med,2007

4. Treatment of lung infection in patients with cystic fibrosis: current and future strategies;Döring;J Cyst Fibros,2012

5. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis;Barker;Am J Respir Crit Care Med,2000

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum LDH and its isoenzymes (LDH2 and LDH5) associated with predictive value for refractory mycoplasma pneumoniae pneumonia in children;Journal of Laboratory Medicine;2024-08-05

2. Qualitative Interviews Exploring Adverse Event Mitigation Strategies in Adults Receiving Amikacin Liposome Inhalation Suspension;Pulmonary Therapy;2024-07-16

3. Airway “Resistotypes” and Clinical Outcomes in Bronchiectasis;American Journal of Respiratory and Critical Care Medicine;2024-07-01

4. Rethinking bronchiectasis as an inflammatory disease;The Lancet Respiratory Medicine;2024-07

5. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults;CHEST;2024-07